Insider Transactions Reported by 16 Insiders of Aligos Therapeutics, Inc.

Symbol
ALGS on Nasdaq
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 10 Jan 2025

Aligos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Heather Preston Director 25 Jun 2025
Margarita Chavez Director 25 Jun 2025
Hardean Achneck Chief Medical Officer 08 Oct 2024
Peter Hirth Director 25 Jun 2025
Carole Nuechterlein Director 25 Jun 2025
Lesley Ann Calhoun Chief Operating Officer and Chief Financial Officer 16 Jul 2025
Matthew W. McClure Chief Medical Officer 01 Mar 2024
ROCHE HOLDING LTD 10%+ Owner 25 Oct 2023
James Paul Scopa Director 25 Jun 2025
Jack Nielsen Director 27 Feb 2024
LAWRENCE BLATT President and CEO, Director 16 Jul 2025
Bridget Martell Director 25 Jun 2025
Julian A. Symons Executive Vice President, Chief Scientific Officer 16 Jul 2025
Leonid Beigelman President, Director 15 Mar 2023
Lucinda Y. Quan Executive Vice President, Chief Business Officer and General Counsel 08 Sep 2023
Thomas Woiwode Director 23 Jun 2022

Recent Insider Transactions by Companies or Individuals for Aligos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.